Ranbaxy: Ranbaxy Buyers Seek OK On $485M Deal In Generics MDL

Ranbaxy Pharmaceuticals drug purchasers asked a Massachusetts federal court Friday to approve their proposed $485 million global settlement with the generic-drug maker and its parent company over antitrust claims, arguing that the agreement provides significant benefits for plaintiffs in the multidistrict litigation.